FIELD: medicine, immunology, pharmacy. SUBSTANCE: invention proposes the use of β-heptyl- -glycoside-N-acetylmuramyl-L-alanyl-D-isoglutamine (C7H15МПД) as an immunomodulating agent and a pharmaceutical composition exhibiting antitumor activity. Composition has an effective amount of β-heptylglycoside MPD and physiologically acceptable filling agents. Preparation promotes an activation of the main links of immunity and can be used for immunity correction in the cases of severe immunodeficiencies. EFFECT: enhanced effectiveness of an immunomodulating activity of an agent. 5 cl, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FOOD ADDITIVE | 1997 |
|
RU2118497C1 |
| DRUG FOR HIV-INFECTION TREATMENT | 2007 |
|
RU2379049C2 |
| MURAMIC ACID DERIVATIVES | 2000 |
|
RU2181729C1 |
| METHOD OF REHABILITATION OF PATIENTS WITH CHRONIC OPISTHOR-CHIASIS AFTER HELMINTHISM TREATMENT | 2000 |
|
RU2162336C1 |
| METHOD FOR SIMULATING IMMUNE-DEPENDENT ALLOGENIC PREGNANCY LOSS IN LABORATORY MICE | 2012 |
|
RU2511107C1 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
| METHOD FOR TREATING PATIENTS WITH CHRONIC GLOMERULONEPHRITIS | 2001 |
|
RU2194526C1 |
| COMPOSITION OF SOLUBLE MONOMERIC AND OLIGOMERIC FRAGMENTS OF PEPTIDOGLYCAN OF THE CELL WALL OF GRAM-NEGATIVE BACTERIA, METHODS FOR PRODUCTION AND APPLICATION THEREOF | 2020 |
|
RU2765270C1 |
| COMPOSITION COMPRISING LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLICANE OF GRAM-NEGATIVE BACTERIA FOR PREVENTING OR TREATING OF HUMAN DISEASES | 2009 |
|
RU2441906C2 |
